DEFA14A ·Filed Aug 21, 2026

NEOG

NEOGEN CORP
NEUTRAL
Impact 2/10
Horizonweeks Processed1mo ago SEC0001193125-26-360749
Proxy solicitation materials
Actionable Insight • Neutral

Monitor for the definitive proxy statement (DEF14A) and any subsequent filings related to the board vacancy or shareholder meeting. The DEFA14A itself is a routine administrative filing with no immediate trading implications.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+20d
NEOG ▲ +13.89% at T+20d
NEUTRAL call ✓ call won +13.89% · α vs SPY +14.42% · entry $11.95 → $13.61
Next anchor: T+60d in 6w
Latest observation: T+26 +1.87% FF3 residual α
Entry anchored
Aug 21, 02:05 PM ET
via 1-min bar
T+1d
-2.93%
call -2.93% · α -2.63%
$11.60
settled 6w ago
T+5d
-2.43%
call -2.43% · α -2.90%
$11.66
settled 5w ago
T+20d
+13.89%
call +13.89% · α +14.42%
$13.61
settled 11d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Neogen Corporation filed additional definitive proxy soliciting materials (DEFA14A) on August 21, 2026. This follows the recent resignation of Director Thierry Bernard on August 3, 2026, reported in an 8-K. The filing is a routine procedural step in the proxy solicitation process with no material financial or operational information disclosed, resulting in a neutral assessment.

Key Facts

  • Neogen filed DEFA14A (additional definitive proxy soliciting materials) on August 21, 2026.
  • Director Thierry Bernard resigned from the board on August 3, 2026, per a prior 8-K filing.
  • No financial figures, voting items, or activist demands are disclosed in the filing documents.

Financial Impact

No financial impact identified from the filing content.

Risk Factors

  • Lack of disclosed content in the DEFA14A limits actionable insight.
  • Director resignation may signal internal governance issues, but no context is provided.

Market Snapshot

Exchange
Nasdaq
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
64% bullish (11 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-360749
Document: 0001193125-26-360749-index-headers.html0001193125-26-360749
Document: 0001193125-26-360749-index.html0001193125-26-360749
Document: 0001193125-26-360749.txt0001193125-26-360749
5 reports for NEOG
Performance horizon
Filters
Rows
Reports for NEOG — sortable, filterable
TypeNow
Aug 21, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$11.95 $13.61▲ +13.89%▲ +14.42%$12.15 (+1.67%)
Aug 7, 2026
8w ago
8-K
NEUTRAL ★ 2/10
$11.40 $11.89▲ +4.25%▲ +5.17%$12.15 (+6.58%)
Jul 30, 2026
9w ago
8-K
MIXED ★ 6/10
$11.53 $11.74▲ +1.82%▼ −2.14%$12.15 (+5.38%)
Apr 20, 2026
23w ago
8-K
NEUTRAL ★ 3/10
$9.63 $8.56▼ −11.11%▼ −15.31%$12.15 (+26.17%)
Apr 9, 2026
25w ago
8-K
MIXED ★ 6/10
$10.04 $9.18▼ −8.57%▼ −16.13%$12.15 (+21.02%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (38h 39m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access